We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.43B
AUM Growth
+$23.4M
Cap. Flow
-$14M
Cap. Flow %
-0.98%
Top 10 Hldgs %
37.26%
Holding
167
New
14
Increased
36
Reduced
54
Closed
10

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.5M
2
PFE icon
Pfizer
PFE
+$6.18M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
4
HRB icon
H&R Block
HRB
+$2.32M
5
PEP icon
PepsiCo
PEP
+$1.41M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$17.2M
2
FLEX icon
Flex
FLEX
+$7.35M
3
PPLI
People Inc
PPLI
+$7.22M
4
AMZN icon
Amazon
AMZN
+$4.45M
5
GLW icon
Corning
GLW
+$3.27M

Sector Composition

Rank Sector Weight
1 Technology 36.12%
2 Financials 18.14%
3 Communication Services 14.85%
4 Healthcare 11.53%
5 Consumer Discretionary 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AET
76
DELISTED
Aetna Inc
AET
$2.93M 0.2%
17,340
– –
JNJ icon
77
Johnson & Johnson
JNJ
$635B
$2.75M 0.19%
21,490
-210
-1% -$28.4K
IBOC icon
78
International Bancshares
IBOC
$4.77B
$2.65M 0.19%
68,230
-1,810
-3% -$73.4K
DXC icon
79
DXC Technology
DXC
$1.63B
$2.57M 0.18%
29,594
– –
DGX icon
80
Quest Diagnostics
DGX
$25.1B
$2.55M 0.18%
25,400
-500
-2% -$51.2K
UNH icon
81
UnitedHealth
UNH
$382B
$2.53M 0.18%
11,840
-1,170
-9% -$267K
CRL icon
82
Charles River Laboratories
CRL
$10.9B
$2.47M 0.17%
23,130
– –
CI icon
83
Cigna
CI
$76.6B
$2.35M 0.16%
14,000
– –
TECK icon
84
Teck Resources
TECK
$29.5B
$2.31M 0.16%
89,814
+5,940
+7% +$167K
LRCX icon
85
Lam Research
LRCX
$382B
$1.88M 0.13%
92,550
– –
BIDU icon
86
Baidu
BIDU
$35.8B
$1.82M 0.13%
8,150
– –
ACH
87
Accendra Health
ACH
$240M
$1.76M 0.12%
113,100
-400
-0.4% -$7.13K
AZN icon
88
AstraZeneca
AZN
$263B
$1.71M 0.12%
24,500
-2,950
-11% -$204K
FFIV icon
89
F5
FFIV
$22.1B
$1.71M 0.12%
11,805
+850
+8% +$122K
ILMN icon
90
Illumina
ILMN
$29.4B
$1.7M 0.12%
7,402
– –
CELG
91
DELISTED
Celgene Corp
CELG
$1.67M 0.12%
18,700
– –
CRUS icon
92
Cirrus Logic
CRUS
$6.74B
$1.55M 0.11%
38,215
– –
CTXS
93
DELISTED
Citrix Systems Inc
CTXS
$1.49M 0.1%
16,090
– –
SIMO icon
94
Silicon Motion
SIMO
$9.19B
$1.49M 0.1%
31,000
– –
GSBC icon
95
Great Southern Bancorp
GSBC
$863M
$1.4M 0.1%
28,010
– –
FTNT icon
96
Fortinet
FTNT
$112B
$1.38M 0.1%
128,700
-125,475
-49% -$1.22M
MDT icon
97
Medtronic
MDT
$107B
$1.29M 0.09%
16,042
-200
-1% -$16.5K
DELL icon
98
Dell
DELL
$283B
$1.27M 0.09%
62,064
– –
SYK icon
99
Stryker
SYK
$127B
$1.25M 0.09%
7,760
-2,940
-27% -$474K
AVTA
100
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.21M 0.08%
49,350
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Oak Associates held 167 positions worth $1.43B, up 1.7% from $1.41B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Oak Associates's Q1 2018 filing shows 14 new, 36 increased, 54 reduced and 10 closed positions. Its largest new stake was KEMET Corporation: 44,595 shares worth $809K. The largest sale was Wells Fargo, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q1 2018 buy was KEMET Corporation: 44,595 shares worth $809K.
  • Oak Associates added most to Gilead Sciences in Q1 2018, an estimated $15.5M increase.
  • Oak Associates's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $17.2M.
  • Oak Associates fully exited Flex in Q1 2018, selling an estimated $7.35M.
  • Oak Associates's ten largest holdings make up 37% of its $1.43B portfolio in Q1 2018.
  • Oak Associates opened 14 new positions and closed 10 in Q1 2018.
  • Oak Associates's portfolio value rose 1.7% quarter-over-quarter to $1.43B.

Based on Oak Associates's 13F filing for Q1 2018, filed 14 May 2018.